The balance between proangiogenic and antiangiogenic factors is key to angiogenesis, in which the binding of vascular endothelial growth factor (VEGF) and its homologous receptor (VEGFR) is the classical pathway of signal transduction in tumor angiogenesis [109]. This evidence concerns the gene KDR and neoplasm.